Artia Global Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,700
| Closed | -$1.63M | – | 37 |
|
|
2025
Q1 | $1.63M | Sell |
14,700
-30,300
| -67% | -$3.35M | 0.41% | 24 |
|
|
2024
Q4 | $6.14M | Hold |
45,000
| – | – | 2.2% | 16 |
|
|
2024
Q3 | $5.18M | Hold |
45,000
| – | – | 1.41% | 13 |
|
|
2024
Q2 | $6.2M | Hold |
45,000
| – | – | 1.2% | 11 |
|
|
2024
Q1 | $6.21M | Hold |
45,000
| – | – | 1.25% | 13 |
|
|
2023
Q4 | $5.93M | Hold |
45,000
| – | – | 1.73% | 9 |
|
|
2023
Q3 | $5.06M | Hold |
45,000
| – | – | 2.1% | 14 |
|
|
2023
Q2 | $4.24M | Hold |
45,000
| – | – | 1.46% | 20 |
|
|
2023
Q1 | $4.55M | Hold |
45,000
| – | – | 1.68% | 14 |
|
|
2022
Q4 | $5.37M | Buy |
+45,000
| New | +$5.37M | 2.05% | 12 |
|